Detalhe da pesquisa
1.
Do non-classic invasive lobular carcinomas derive a benefit from neoadjuvant chemotherapy?
Breast Cancer Res Treat
; 197(2): 417-423, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36394689
2.
Does a brief surgeon training in negotiation theory principles decrease rates of contralateral prophylactic mastectomy?
Breast Cancer Res Treat
; 199(1): 119-126, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36881270
3.
Mutational Status is Associated with a Higher Rate of Pathologic Complete Response After Neoadjuvant Chemotherapy in Hormone Receptor-Positive Breast Cancer.
Ann Surg Oncol
; 30(13): 8412-8418, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37798552
4.
Is local recurrence higher among patients who downstage to breast conservation after neoadjuvant chemotherapy?
Cancer
; 128(3): 471-478, 2022 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34597420
5.
Local Recurrence is Frequent After Heroic Mastectomy for Classically Inoperable Breast Cancers.
Ann Surg Oncol
; 29(2): 1043-1048, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34522999
6.
Margin Width and Local Recurrence in Patients Undergoing Breast Conservation After Neoadjuvant Chemotherapy.
Ann Surg Oncol
; 29(1): 484-492, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34331159
7.
Omission of Intraoperative Frozen Section May Reduce Axillary Overtreatment Among Clinically Node-Negative Patients Having Upfront Mastectomy.
Ann Surg Oncol
; 29(13): 8037-8043, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35951137
8.
The Effect of Age on Outcomes After Neoadjuvant Chemotherapy for Breast Cancer.
Ann Surg Oncol
; 29(6): 3810-3819, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35246810
9.
Adoption of SSO-ASTRO Margin Guidelines for Ductal Carcinoma in Situ: What Is the Impact on Use of Additional Surgery?
Ann Surg Oncol
; 28(1): 295-302, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32500343
10.
Extranodal Tumor Deposits in the Axillary Fat Indicate the Need for Axillary Dissection Among T1-T2cN0 Patients with Positive Sentinel Nodes.
Ann Surg Oncol
; 27(10): 3585-3592, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32488512
11.
Selecting Node-Positive Patients for Axillary Downstaging with Neoadjuvant Chemotherapy.
Ann Surg Oncol
; 27(11): 4515-4522, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32488513
12.
Why Are There So Many Mastectomies in the United States?
Annu Rev Med
; 68: 229-241, 2017 01 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-27576011
13.
Lobular Histology Does Not Predict the Need for Axillary Dissection Among ACOSOG Z0011-Eligible Breast Cancers.
Ann Surg Oncol
; 26(10): 3269-3274, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31342363
14.
Was Reexcision Less Frequent for Patients with Lobular Breast Cancer After Publication of the SSO-ASTRO Margin Guidelines?
Ann Surg Oncol
; 26(12): 3856-3862, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31456094
15.
Impact of Age on Locoregional and Distant Recurrence After Mastectomy for Ductal Carcinoma In Situ With or Without Microinvasion.
Ann Surg Oncol
; 26(13): 4264-4271, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31440931
16.
Is Clinical Exam of the Axilla Sufficient to Select Node-Positive Patients Who Downstage After NAC for SLNB? A Comparison of the Accuracy of Clinical Exam Versus MRI.
Ann Surg Oncol
; 26(13): 4238-4243, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31583546
17.
Treatment Strategies in Octogenarians with Early-Stage, High-Risk Breast Cancer.
Ann Surg Oncol
; 25(6): 1495-1501, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29427213
18.
ASO Visual Abstract: Mutational Status is Associated with Higher Rate of Pathologic Complete Response After Neoadjuvant Chemotherapy in Hormone Receptor-Positive Breast Cancer.
Ann Surg Oncol
; 30(13): 8469-8470, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37815683
19.
Are there patients with T1 to T2, lymph node-negative breast cancer who are "high-risk" for locoregional disease recurrence?
Cancer
; 123(14): 2626-2633, 2017 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28334423
20.
Axillary Dissection and Nodal Irradiation Can Be Avoided for Most Node-positive Z0011-eligible Breast Cancers: A Prospective Validation Study of 793 Patients.
Ann Surg
; 266(3): 457-462, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28650355